Page 48 - Predicting survival in patients with spinal bone metastasesL
P. 48
CHAPTER III REFERENCES
1. Quan GM, Vital J-M, Aurouer N, et al. Surgery improves pain, function and quality of life in patients with spinal metastases: a prospective study on 118 patients. Eur Spine J. 2011;20(11):1970–8.
2. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643– 8.
3. Jansson KA, Bauer HC. Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases. Eur Spine J. 2006;15(2):196-202.
4. Tokuhashi Y, Matsuzaki H, Toriyama S, et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine. 1990;15(11):1110–3.
5. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186-91.
6. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine. 2001;26(3):298- 306.
7. Linden YM, Dijkstra PDS, Vonk E, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer. 2005;103(2):320-8.
8. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases: Prognostication in 241 patients. Acta Orthop Scand. 1995;66(2)143-6.
9. Karnofsky DA, Abelmann WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. with particular reference to bronchogenic carcinoma. Cancer. 1948;(1):634- 656.
10. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2(3):187–93.
11. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Spinal Cord. 1969;7(3):179–92.
12. Wibmer C, Leithner A, Hofmann G, et al. Survival analysis of 254 patients after manifestation of spinal metastases - evaluation of seven preoperative scoring systems. Spine. 2011;36(23):1977-86.
13. Rades D, Douglas S, Veninga T, et al. Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol. 2012;188(4):340-5.
14. Yamashita T, Siemionow KB, Mroz TE, et al. A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised Tokuhashi score. Spine. 2011;36(11):910–7.
15. Crnalic S, Hildingsson C, Wikström P, et al. Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer. Acta Orthop. 2011;83(1):80-86.
16. Chow E, Harth T, Hruby G, et al. How accurate are physicians’ clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol. 2001;13(3):209–18.
17. Pointillart V, Vital J-M, Salmi R, et al. Survival prognostic factors and clinical outcomes in patients with spinal metastases. J Cancer Res Clin Oncol. 2011;137(5):849–56.
18. Chi JH, Gokaslan Z, McCormick P, et al. Selecting treatment for patients with malignant epidural spinal cord compression-does age matter? Results from a randomized clinical trial. Spine. 2009;34(5):431–5.
19. Tancioni F, Navarria P, Pessina F, et al. Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience. Eur Spine J. 2012;21(1):146-8.
46